In contrast, a negative or non-significant correlation was identified between the drug-resistant T790M mutation and PD-1/PD-L1 expression, suggesting that strong PD-L1 expression may be more prevalent in T790M-negative NSCLC patients than in their T790M-positive counterparts. The gene discussed is CD274; the disease is non-small cell lung carcinoma.